RALEIGH, N.C., Oct. 28 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will exhibit at the 61st conference of the American Association for the Study of Liver Diseases, The Liver Meeting®, being held 30 October – 1 November 2010 in Boston, Massachusetts, USA.
Representatives from PRA's Infectious Diseases Research Center and other departments will be available at booth 300 to discuss our expertise in hepatitis B & C as well as other liver diseases.
Because infectious disease is one of PRA's core therapeutic areas, we have a proven record of accomplishment in hepatitis B & C study management and drug development from early phase through NDA submission. PRA also offers clients the benefit of centralized, coordinated activities through our Infectious Diseases Research Center. This cross-functional department is comprised of staff from Scientific Affairs, Project Management, Patient Recruitment, Corporate Development and Clinical Informatics.
For more information about the conference, navigate to www.praintl.com and click on "Events." The Liver Meeting® is a registered trademark of the American Association for the Study of Liver Diseases.
About PRA International
PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Infectious Diseases, Oncology, Neurosciences, Respiratory/Allergy and Cardiovascular. In the last five years, PRA has supported over 3000 clinical trials through its 38 global offices.
PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
SOURCE PRA International